Block Lagged Peers as Insiders Sold Into Strength
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Block, Inc. added 1.6% over the past week, closing Tuesday at $78.10. That trails the median gain of 2.7% across its closest correlated peers: RKT rose 3.9%, GPN 3.6%, and FOUR 4.2%, while AFRM was the only peer to lose ground, down 5.2%. Block's underperformance came as a director sold stock every single trading day for at least two weeks, and Wikipedia-measured retail attention hit a three-standard-deviation spike.
The insider activity is mechanical in origin but worth noting for its scale. Director Anthony Eisen sold 6,000 shares each trading day between October 6 and October 19, filing under a pre-arranged 10b5-1 plan. Over the 90-day window, Block insiders collectively sold a net 280,686 shares for roughly $22.1 million. Because these are plan-driven sales, they carry less signal than a discretionary disposal, but the steady drip of supply at prices between $75 and $80 is a visible overhead feature in the tape.
Short positioning tells a different story. At 2.6% of the free float, short interest is low and has gone essentially nowhere on the week, edging down 0.4%. Borrowing costs are negligible at 0.43%, and borrow availability is about as loose as it gets, with shares available to borrow running at multiples of what is currently borrowed. The ORTEX short score of 33.5 sits in the bottom half of the universe, consistent with a stock that does not attract meaningful short-side conviction. Nothing in the lending market points to pressure in either direction.
The Street is tilted constructively. Most coverage holds a positive rating, with targets ranging from $75 at the cautious end to $115 at the top. RBC Capital reiterated Outperform and a $95 target as recently as this morning. Baird raised its target to $106 at the start of the month, keeping Outperform. Macquarie is the clearest dissenter, sitting at Neutral with a $75 target that sits roughly at current market prices. The consensus mean of $97.86 implies about 25% upside from Tuesday's close. Bulls point to 22% projected gross profit growth to $2.8 billion, with Cash App monthly transacting actives at 59 million and deepening Square synergies. Bears flag take-rate compression, operating-system wallet competition, and BNPL regulatory exposure as drags on the revenue story. Valuation sits at 15.7x trailing earnings and 8.8x EV/EBITDA, both largely stable over the past month.
One data point outside the financial signals: Wikipedia page views for Block have spiked to a z-score of 3.0 against the company's own prior 90 days, placing retail attention well above its recent norm. ORTEX flags this as an attention signal rather than a revenue indicator, so it does not read across to the fundamental picture. But elevated retail attention heading into a scheduled earnings release on November 3 is worth noting alongside the options market, where the put/call ratio of 0.68 is running modestly above its 20-day average of 0.65, a slight drift toward hedging without reaching anything close to alarm.
The prior two earnings prints produced consistent reactions: the August 2026 report sent the stock down 6.6% on the day and a further 0.9% over the following week, and the June print produced a 2.0% drop on the day. With thirteen days to the next release, the November 3 print is the concrete event to frame against current positioning, specifically whether gross profit growth and Cash App engagement data can shift analyst conviction at firms still sitting on neutral-to-cautious targets.
Stocks in this article
See the live data behind this article on ORTEX.
Open XYZ on ORTEX →How this article was generated
- Generated
- 21 Oct 2026, 20:12
- Data as of
- 21 Oct 2026, 20:03
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.